NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2023
CVR: 24257908
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -40,804 and a net result of DKK -4,027,032 compared with DKK -2,970,513 the year before. Equity in the 2023 report amounted to DKK 24,976,937. The solvency ratio was 99.8%.
- Gross Profit
- DKK -40,804
- Profit/Loss
- DKK -4,027,032
- Equity
- DKK 24,976,937
- Total Assets
- DKK 25,015,712
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -41K | -4M | 25M | - |
| 2022 | - | -37K | -3M | 29M | 0 |
| 2021 | - | -32K | 637K | 29.5M | 0 |
| 2020 | - | -32K | 2.5M | 28.8M | 0 |
| 2019 | - | -38K | -32K | 26.4M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 2, 2023, Rainer Chapour Lehmann has joined the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of November 2, 2023, Lars Green has left the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2022. Gross profit came to DKK -36,983, and the net result was DKK -2,970,513.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.